Cogent Biosciences, Inc. (COGT)
36.23
-0.50
(-1.36%)
USD |
NASDAQ |
Aug 24, 16:00
36.23
0.00 (0.00%)
After-Hours: 19:19
Cogent Biosciences Debt to Equity Ratio : 0.4588 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4588 |
| March 31, 2026 | 0.3927 |
| December 31, 2025 | 0.3752 |
| September 30, 2025 | 0.2002 |
| June 30, 2025 | 0.3913 |
| March 31, 2025 | 0.078 |
| December 31, 2024 | 0.0682 |
| September 30, 2024 | 0.0567 |
| June 30, 2024 | 0.0487 |
| March 31, 2024 | 0.0439 |
| December 31, 2023 | 0.0731 |
| September 30, 2023 | 0.0633 |
| June 30, 2023 | 0.0556 |
| March 31, 2023 | 0.0871 |
| December 31, 2022 | 0.0768 |
| September 30, 2022 | 0.0693 |
| June 30, 2022 | 0.0879 |
| March 31, 2022 | 0.0187 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.0147 |
| September 30, 2021 | 0.0187 |
| June 30, 2021 | 0.0198 |
| March 31, 2021 | 0.0208 |
| December 31, 2020 | 0.0222 |
| September 30, 2020 | -6.490 |
| June 30, 2020 | 0.2725 |
| March 31, 2020 | 0.2196 |
| December 31, 2019 | 0.1899 |
| September 30, 2019 | 0.224 |
| June 30, 2019 | 0.1707 |
| March 31, 2019 | 0.1451 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Apogee Therapeutics, Inc. | 0.0888 |
| ImmunityBio, Inc. | -1.174 |
| Erasca, Inc. | 0.1236 |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 834.55M |
| Total Liabilities (Quarterly) | 302.16M |
| Shareholders Equity (Quarterly) | 532.39M |
| Current Ratio | 13.57 |
| Net Debt Paydown Yield | -0.68% |